SYED AHMED: Open Payments
NPI 1003828526 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 52 payments from 17 companies in 2025. Trend: 2023 $8,614 · 2024 $7,342 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $183 |
| Alkermes, Inc. | 6 | $147 |
| Indivior Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $97 |
| Neurocrine BioSciences, Inc. | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Bausch Health US, LLC | 2 | $44 |
| UCB, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
Products named: REXULTI, CAPLYTA, ARISTADA, SUBLOCADE, FANAPT, INGREZZA, AUSTEDO XR, Bimzelx.
Industry payments across NY — which companies pay providers there.
